Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin.

Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin. Int J Biol Markers. 2009 Oct-Dec; 24(4):265-70.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.